|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar
|
|
3
|
Ilic M and Ilic I: Epidemiology of
pancreatic cancer. World J Gastroenterol. 22:9694–9705. 2016.
View Article : Google Scholar
|
|
4
|
Chu LC, Goggins MG and Fishman EK:
Diagnosis and detection of pancreatic cancer. Cancer J. 23:333–342.
2017. View Article : Google Scholar
|
|
5
|
Ansari D, Tingstedt B, Andersson B,
Holmquist F, Sturesson C, Williamsson C, Sasor A, Borg D, Bauden M
and Andersson R: Pancreatic cancer: Yesterday, today and tomorrow.
Future Oncol. 12:1929–1946. 2016. View Article : Google Scholar
|
|
6
|
Risch HA, Lu L, Kidd MS, Wang J, Zhang W,
Ni Q, Gao YT and Yu H: Helicobacter pylori seropositivities
and risk of pancreatic carcinoma. Cancer Epidemiol Biomarkers Prev.
23:172–178. 2014. View Article : Google Scholar
|
|
7
|
Rabelo-Goncalves EM, Roesler BM and
Zeitune JM: Extragastric manifestations of Helicobacter
pylori infection: Possible role of bacterium in liver and
pancreas diseases. World J Hepatol. 7:2968–2979. 2015. View Article : Google Scholar
|
|
8
|
Dougan SK: The pancreatic cancer
microenvironment. Cancer J. 23:321–325. 2017. View Article : Google Scholar
|
|
9
|
Rojas A, Araya P, Gonzalez I and Morales
E: Gastric tumor microenvironment. Adv Exp Med Biol. 1226:23–35.
2020. View Article : Google Scholar
|
|
10
|
Sethi V, Vitiello GA, Saxena D, Miller G
and Dudeja V: The role of the microbiome in immunologic development
and its implication for pancreatic cancer immunotherapy.
Gastroenterology. 156:2097–2115.e2. 2019. View Article : Google Scholar
|
|
11
|
Wessler S, Krisch LM, Elmer DP and Aberger
F: From inflammation to gastric cancer-the importance of
Hedgehog/GLI signaling in Helicobacter pylori-induced
chronic inflammatory and neoplastic diseases. Cell Commun Signal.
15:152017. View Article : Google Scholar
|
|
12
|
Maisonneuve P and Lowenfels AB: Risk
factors for pancreatic cancer: A summary review of meta-analytical
studies. Int J Epidemiol. 44:186–198. 2015. View Article : Google Scholar
|
|
13
|
Chen L, Xu W, Lee A, He J, Huang B, Zheng
W, Su T, Lai S, Long Y, Chu H, et al: The impact of Helicobacter
pylori infection, eradication therapy and probiotic
supplementation on gut microenvironment homeostasis: An open-label,
randomized clinical trial. EBioMedicine. 35:87–96. 2018. View Article : Google Scholar
|
|
14
|
Noto JM and Peek RM Jr: The gastric
microbiome, its interaction with Helicobacter pylori, and
its potential role in the progression to stomach cancer. PLoS
Pathog. 13:e10065732017. View Article : Google Scholar
|
|
15
|
Wen S, Velin D, Felley CP, Du L, Michetti
P and Pan-Hammarstrom Q: Expression of Helicobacter pylori
virulence factors and associated expression profiles of
inflammatory genes in the human gastric mucosa. Infect Immun.
75:5118–5126. 2007. View Article : Google Scholar
|
|
16
|
Echizen K, Horiuchi K, Aoki Y, Yamada Y,
Minamoto T, Oshima H and Oshima M: NF-κB-induced NOX1 activation
promotes gastric tumorigenesis through the expansion of
SOX2-positive epithelial cells. Oncogene. 38:4250–4263. 2019.
View Article : Google Scholar
|
|
17
|
Costa AM, Ferreira RM, Pinto-Ribeiro I,
Sougleri IS, Oliveira MJ, Carreto L, Santos MA, Sgouras DN,
Carneiro F, Leite M and Figueiredo C: Helicobacter pylori
activates matrix metalloproteinase 10 in gastric epithelial cells
via EGFR and ERK-mediated pathways. J Infect Dis. 213:1767–1776.
2016. View Article : Google Scholar
|
|
18
|
Galamb O, Gyorffy B, Sipos F, Dinya E,
Krenács T, Berczi L, Szõke D, Spisák S, Solymosi N, Németh AM, et
al: Helicobacter pylori and antrum erosion-specific gene
expression patterns: The discriminative role of CXCL13 and VCAM1
transcripts. Helicobacter. 13:112–126. 2008. View Article : Google Scholar
|
|
19
|
Koutsioumpa M, Hatziapostolou M,
Polytarchou C, Tolosa EJ, Almada LL, Mahurkar-Joshi S, Williams J,
Tirado-Rodriguez AB, Huerta-Yepez S, Karavias D, et al: Lysine
methyltransferase 2D regulates pancreatic carcinogenesis through
metabolic reprogramming. Gut. 68:1271–1286. 2019. View Article : Google Scholar
|
|
20
|
Lunardi S, Jamieson NB, Lim SY, Griffiths
KL, Carvalho-Gaspar M, Al-Assar O, Yameen S, Carter RC, McKay CJ,
Spoletini G, et al: IP-10/CXCL10 induction in human pancreatic
cancer stroma influences lymphocytes recruitment and correlates
with poor survival. Oncotarget. 5:11064–11080. 2014. View Article : Google Scholar
|
|
21
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar
|
|
22
|
Kanehisa M: The KEGG database. Novartis
Found Symp. 247:91–103, 119–128, 244–252. 2002. View Article : Google Scholar
|
|
23
|
Tomczak K, Czerwinska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.
|
|
24
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. (45W):
W98–W102. 2017. View Article : Google Scholar
|
|
25
|
Barretina J, Caponigro G, Stransky N,
Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV,
Sonkin D, et al: The cancer cell line encyclopedia enables
predictive modelling of anticancer drug sensitivity. Nature.
483:603–607. 2012. View Article : Google Scholar
|
|
26
|
Pei H, Li L, Fridley BL, Jenkins GD,
Kalari KR, Lingle W, Petersen G, Lou Z and Wang L: FKBP51 affects
cancer cell response to chemotherapy by negatively regulating Akt.
Cancer Cell. 16:259–266. 2009. View Article : Google Scholar
|
|
27
|
Wagner KW, Punnoose EA, Januario T,
Lawrence DA, Pitti RM, Lancaster K, Lee D, von Goetz M, Yee SF,
Totpal K, et al: Death-receptor O-glycosylation controls tumor-cell
sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med.
13:1070–1077. 2007. View
Article : Google Scholar
|
|
28
|
Chen X, Cheung ST, So S, Fan ST, Barry C,
Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, et al: Gene expression
patterns in human liver cancers. Mol Biol Cell. 13:1929–1939. 2002.
View Article : Google Scholar
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
30
|
Bastidas-Ponce A, Scheibner K, Lickert H
and Bakhti M: Cellular and molecular mechanisms coordinating
pancreas development. Development. 144:2873–2888. 2017. View Article : Google Scholar
|
|
31
|
Storz P and Crawford HC: Carcinogenesis of
pancreatic ductal adenocarcinoma. Gastroenterology. 158:2072–2081.
2020. View Article : Google Scholar
|
|
32
|
The Lancet Gastroenterology Hepatology:
Pancreatic cancer: How can we tackle the lack of progress? Lancet
Gastroenterol Hepatol. 2:732017. View Article : Google Scholar
|
|
33
|
Jin G, Hong W, Guo Y, Bai Y and Chen B:
Molecular mechanism of pancreatic stellate cells activation in
chronic pancreatitis and pancreatic cancer. J Cancer. 11:1505–1515.
2020. View Article : Google Scholar
|
|
34
|
Kenner BJ: Early detection of pancreatic
cancer: The role of depression and anxiety as a precursor for
disease. Pancreas. 47:363–367. 2018. View Article : Google Scholar
|
|
35
|
Malats N, Molina-Montes E and La Vecchia
C: Genomics in primary and secondary prevention of pancreatic
cancer. Public Health Genomics. 20:92–99. 2017. View Article : Google Scholar
|
|
36
|
Hunt RH, Camilleri M, Crowe SE, El-Omar
EM, Fox JG, Kuipers EJ, Malfertheiner P, McColl KE, Pritchard DM,
Rugge M, et al: The stomach in health and disease. Gut.
64:1650–1668. 2015. View Article : Google Scholar
|
|
37
|
Norris AW and Uc A: A novel
stomach-pancreas connection: More than physical. EBioMedicine.
37:25–26. 2018. View Article : Google Scholar
|
|
38
|
Holst JJ, Knuhtsen S, Jensen SL,
Fahrenkrug J, Larsson LI and Nielsen OV: Interrelation of nerves
and hormones in stomach and pancreas. Scand J Gastroenterol Suppl.
82:85–99. 1983.
|
|
39
|
Wang F, Meng W, Wang B and Qiao L:
Helicobacter pylori-induced gastric inflammation and gastric
cancer. Cancer Lett. 345:196–202. 2014. View Article : Google Scholar
|
|
40
|
Wroblewski LE and Peek RM Jr:
Helicobacter pylori, cancer, and the gastric microbiota. Adv
Exp Med Biol. 908:393–408. 2016. View Article : Google Scholar
|
|
41
|
Bravo D, Hoare A, Soto C, Valenzuela MA
and Quest AF: Helicobacter pylori in human health and
disease: Mechanisms for local gastric and systemic effects. World J
Gastroenterol. 24:3071–3089. 2018. View Article : Google Scholar
|
|
42
|
Yadav D and Lowenfels AB: The epidemiology
of pancreatitis and pancreatic cancer. Gastroenterology.
144:1252–1261. 2013. View Article : Google Scholar
|
|
43
|
Venerito M, Vasapolli R, Rokkas T,
Delchier JC and Malfertheiner P: Helicobacter pylori,
gastric cancer and other gastrointestinal malignancies.
Helicobacter. Sep 22–2017.(Epub ahead of print): doi:
10.1111/hel.12413. 2017. View Article : Google Scholar
|
|
44
|
Goral V: Pancreatic cancer: Pathogenesis
and diagnosis. Asian Pac J Cancer Prev. 16:5619–5624. 2015.
View Article : Google Scholar
|
|
45
|
Carraway KL, Theodoropoulos G, Kozloski GA
and Carothers Carraway CA: Muc4/MUC4 functions and regulation in
cancer. Future Oncol. 5:1631–1640. 2009. View Article : Google Scholar
|
|
46
|
Gautam SK, Kumar S, Dam V, Ghersi D, Jain
M and Batra SK: MUCIN-4 (MUC4) is a novel tumor antigen in
pancreatic cancer immunotherapy. Semin Immunol. 47:1013912020.
View Article : Google Scholar
|
|
47
|
Jahan R, Macha MA, Rachagani S, Das S,
Smith LM, Kaur S and Batra SK: Axed MUC4 (MUC4/X) aggravates
pancreatic malignant phenotype by activating integrin-β1/FAK/ERK
pathway. Biochim Biophys Acta Mol Basis Dis. 1864:2538–2549. 2018.
View Article : Google Scholar
|
|
48
|
Gautam SK, Kumar S, Cannon A, Hall B,
Bhatia R, Nasser MW, Mahapatra S, Batra SK and Jain M: MUC4 mucin-a
therapeutic target for pancreatic ductal adenocarcinoma. Expert
Opin Ther Targets. 21:657–669. 2017. View Article : Google Scholar
|
|
49
|
Vasseur R, Skrypek N, Duchêne B, Renaud F,
Martínez-Maqueda D, Vincent A, Porchet N, Van Seuningen I and
Jonckheere N: The mucin MUC4 is a transcriptional and
post-transcriptional target of K-ras oncogene in pancreatic cancer.
Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
Biochim Biophys Acta. 1849:1375–1384. 2015. View Article : Google Scholar
|
|
50
|
Cho JS, Park MH, Lee JS and Yoon JH:
Reduced MUC4 expression is a late event in breast carcinogenesis
and is correlated with increased infiltration of immune cells as
well as promoter hypermethylation in invasive breast carcinoma.
Appl Immunohistochem Mol Morphol. 23:44–53. 2015. View Article : Google Scholar
|
|
51
|
Karamitopoulou E: Tumour microenvironment
of pancreatic cancer: Immune landscape is dictated by molecular and
histopathological features. Br J Cancer. 121:5–14. 2019. View Article : Google Scholar
|
|
52
|
Ren B, Cui M, Yang G, Wang H, Feng M, You
L and Zhao Y: Tumor microenvironment participates in metastasis of
pancreatic cancer. Mol Cancer. 17:1082018. View Article : Google Scholar
|
|
53
|
Carraway KL, Perez A, Idris N, Jepson S,
Arango M, Komatsu M, Haq B, Price-Schiavi SA, Zhang J and Carraway
CA: Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in
cancer and epithelia: To protect and to survive. Prog Nucleic Acid
Res Mol Biol. 71:149–185. 2002. View Article : Google Scholar
|
|
54
|
Miyahara N, Shoda J, Kawamoto T, Ishida H,
Ueda T, Akimoto Y, Kawakami H and Irimura T: Interaction of Muc4
and ErbB2 in a transgenic mouse model of gallbladder carcinoma:
Potential pathobiological implications. Oncol Rep. 32:1796–1802.
2014. View Article : Google Scholar
|
|
55
|
Liberelle M, Magnez R, Thuru X, Bencheikh
Y, Ravez S, Quenon C, Drucbert AS, Foulon C, Melnyk P, Van
Seuningen I and Lebègue N: MUC4-ErbB2 oncogenic complex: Binding
studies using microscale thermophoresis. Sci Rep. 9:166782019.
View Article : Google Scholar
|
|
56
|
Seshacharyulu P, Ponnusamy MP, Rachagani
S, Lakshmanan I, Haridas D, Yan Y, Ganti AK and Batra SK: Targeting
EGF-receptor(s)-STAT1 axis attenuates tumor growth and metastasis
through downregulation of MUC4 mucin in human pancreatic cancer.
Oncotarget. 6:5164–5181. 2015. View Article : Google Scholar
|
|
57
|
Hanada K, Uchida T, Tsukamoto Y, Watada M,
Yamaguchi N, Yamamoto K, Shiota S, Moriyama M, Graham DY and
Yamaoka Y: Helicobacter pylori infection introduces DNA
double-strand breaks in host cells. Infect Immun. 82:4182–4189.
2014. View Article : Google Scholar
|
|
58
|
Chinaranagari S, Sharma P, Bowen NJ and
Chaudhary J: Prostate cancer epigenome. Methods Mol Biol.
1238:125–140. 2015. View Article : Google Scholar
|
